Selinexor in Combination with Decitabine in Patients with Acute Myeloid Leukemia: Results from a Phase 1 study

Current treatment options for older and relapsed or refractory (R/R) acute myeloid leukemia (AML) patients are limited and represent an unmet need. Based on preclinical studies showing strong anti-leukemic effects in vivo, this phase I dose-escalation study assessed the safety and preliminary clinic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leuk Lymphoma
Main Authors: Bhatnagar, Bhavana, Zhao, Qiuhong, Mims, Alice S., Vasu, Sumithira, Behbehani, Gregory K., Larkin, Karilyn, Blachly, James S., Blum, William, Klisovic, Rebecca B., Ruppert, Amy S., Orwick, Shelley, Oakes, Christopher, Ranganathan, Parvathi, Byrd, John C., Walker, Alison R., Garzon, Ramiro
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7552944/
https://ncbi.nlm.nih.gov/pubmed/31545113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2019.1665664
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados